Clinical Trials for Array Biopharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Array Biopharma

Clinical Trials (4)

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

PHASE2Recruiting

25 participants

Started: Mar 3, 2021 · Completed: May 31, 2027

2 conditions2 sponsors2 locations

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

PHASE1/PHASE2Active, not recruiting

70 participants

Started: Jun 11, 2020 · Completed: Oct 1, 2025

5 conditions2 sponsors1 location

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

PHASE2Recruiting

150 participants

Started: Jul 8, 2019 · Completed: Jun 30, 2026

9 conditions8 sponsors12 locations

Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

PHASE1Active, not recruiting

34 participants

Started: May 31, 2017 · Completed: Dec 31, 2025

1 condition3 sponsors1 location